SNP	PROBSET_ID	GENE	CHR	BETA	BETA_SE	PVAL	TRAIT
rs3815171	8024120	ABCA7	19	-0.206977	0.156213	1.83E-06	Alzheimer's disease
rs1044573	8065469	ABHD12	20	-0.307053	0.0716121	4.40E-14	Allergic rhinitis
rs3110496	8013919	ABHD15	17	0.27707	0.0462798	3.12E-09	Height
rs211718	7902367	ACADM	1	0.323774	0.0858661	2.56E-17	Metabolic traits
rs211718	7902367	ACADM	1	0.323774	0.0858661	2.56E-17	Metabolite levels
rs10970976	8154733	ACO1	9	0.157859	0.0936985	3.69E-05	Asthma
rs3817334	7947815	ACP2	11	-0.216902	0.0476503	7.23E-06	Body mass index
rs7932354	7947815	ACP2	11	-0.261562	0.0466609	2.98E-08	Bone mineral density
rs7932354	7947815	ACP2	11	-0.261562	0.0466609	2.98E-08	Bone mineral density (hip)
rs7944584	7947815	ACP2	11	-0.334118	0.117305	1.24E-14	Fasting glucose-related traits
rs7120118	7947815	ACP2	11	0.494261	0.0870388	9.26E-37	HDL cholesterol
rs3136441	7947815	ACP2	11	0.28717	0.0458868	5.90E-10	HDL cholesterol
rs2234978	7934906	ACTA2	10	-0.149645	0.193328	9.80E-17	Immunoglobulin A 
rs11740562	8115490	ADAM19	5	-0.225817	0.0885037	2.75E-06	Bipolar disorder and schizophrenia
rs713586	8050766	ADCY3	2	-0.305276	0.0757713	1.40E-14	Body mass index
rs1530016	8050766	ADCY3	2	0.250607	0.0469392	1.30E-07	Type 1 diabetes 
rs7924176	7928471	ADK	10	0.167154	0.108676	6.80E-07	Permanent tooth development
rs7924176	7928471	ADK	10	0.167154	0.108676	6.80E-07	Primary tooth development (number of teeth)
rs7924176	7928471	ADK	10	0.167154	0.108676	6.80E-07	Primary tooth development (time to first tooth eruption)
rs13208505	8129728	AHI1	6	0.588681	0.0329908	1.27E-70	Multiple sclerosis 
rs397969	8013431	AKAP10	17	-0.353785	0.0862133	2.75E-16	Platelet counts
rs1046943	8128795	AKD1	6	0.274397	0.0888843	1.91E-09	Height
rs4732038	8143054	AKR1B1	7	-0.26667	0.0760163	1.03E-09	Longevity
rs2280401	8030321	ALDH16A1	19	0.374573	0.156486	1.39E-10	Hematological and biochemical traits
rs2280401	8030321	ALDH16A1	19	0.374573	0.156486	1.39E-10	Serum albumin level
rs2280401	8030321	ALDH16A1	19	0.374573	0.156486	1.39E-10	Serum total protein level
rs2238151	7958784	ALDH2	12	-0.13884	0.121563	2.34E-06	Stroke (ischemic)
rs2239557	7980098	ALDH6A1	14	0.239121	0.102918	5.57E-08	Common traits (Other)
rs9309473	8042737	ALMS1	2	-0.289343	0.0553824	1.44E-08	Metabolite levels
rs35349669	8049128	ALPPL2	2	0.18601	0.101046	5.75E-05	Alzheimer's disease
rs10935120	8090866	ANAPC13	3	-0.456818	0.0397894	4.28E-30	Height
rs16877106	8094408	ANAPC4	4	-0.229198	0.052852	1.76E-05	Weight
rs2028299	7991335	ANPEP	15	0.190564	0.172713	1.52E-15	Type 2 diabetes
rs6586030	7934733	ANXA11	10	-0.124877	0.111509	2.32E-05	Inflammatory bowel disease
rs1953600	7934733	ANXA11	10	-0.257614	0.122069	2.46E-13	Sarcoidosis
rs16971217	8006542	AP2B1	17	0.231528	0.0473722	1.39E-06	Mean platelet volume
rs2405442	8134712	AP4M1	7	-0.271543	0.0463778	6.84E-09	Alzheimer's disease
rs2054989	8088247	ARHGEF3	3	-0.212795	0.0537427	1.61E-05	Hip geometry
rs183211	8016300	ARL17A	17	-0.22127	0.0862981	3.04E-05	Ovarian cancer in BRCA1 mutation carriers 
rs183211	8016285	ARL17A	17	-0.219965	0.089377	3.38E-05	Ovarian cancer in BRCA1 mutation carriers 
rs183211	8007794	ARL17A	17	-0.21621	0.082469	4.72E-05	Ovarian cancer in BRCA1 mutation carriers 
rs2292354	7966315	ARPC3	12	-0.103934	0.140426	1.61E-06	Metabolic syndrome
rs4965121	7986350	ARRDC4	15	0.138927	0.119277	2.09E-05	Neuroticism
rs7914558	7930181	AS3MT	10	0.472292	0.0525349	1.95E-33	"Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)"
rs7914558	7930181	AS3MT	10	0.472292	0.0525349	1.95E-33	Schizophrenia
rs4823077	8075285	ASCC2	22	0.101159	0.182162	4.76E-06	Crohn's disease 
rs2412973	8075285	ASCC2	22	0.114529	0.164574	3.20E-05	Inflammatory bowel disease (early onset)
rs5763751	8075285	ASCC2	22	0.0583671	0.221775	1.05E-08	Type 1 diabetes 
rs4823077	8075285	ASCC2	22	0.101159	0.182162	4.76E-06	Ulcerative colitis 
rs2463822	7940643	ASRGL1	11	0.363902	0.0484871	1.09E-13	Chronic obstructive pulmonary disease-related biomarkers
rs12103	7896961	ATAD3B	1	-0.233509	0.085732	8.31E-06	Inflammatory bowel disease
rs1801516	7943620	ATM	11	0.22415	0.0529724	2.82E-05	Melanoma
rs11212617	7943620	ATM	11	0.29562	0.0456209	1.43E-10	Response to metformin
rs1320976	7907160	ATP1B1	1	0.207104	0.0478459	2.03E-05	QT interval
rs1641537	8004545	ATP1B2	17	0.268274	0.0621624	1.56E-08	Sex hormone-binding globulin levels
rs46522	8008132	ATP5G1	17	0.206731	0.0624309	2.93E-05	Coronary heart disease
rs11170631	7963713	ATP5G2	12	-0.259436	0.0717786	1.51E-09	Height
rs6488898	7959657	ATP6V0A2	12	0.269661	0.0572895	2.85E-07	Adiponectin levels
rs6429082	7925229	B3GALNT2	1	0.200753	0.19203	6.54E-15	Adiposity
rs1047964	7951910	BACE1	11	-0.278549	0.0476014	1.89E-09	Cardiovascular disease risk factors
rs372883	8068100	BACH1	21	0.205002	0.0479317	2.56E-05	Pancreatic cancer
rs16887244	8145914	BAG4	8	-0.20857	0.0763394	4.88E-05	Schizophrenia
rs6435862	8058695	BARD1	2	-0.254288	0.0554058	2.33E-08	Neuroblastoma (high-risk)
rs57348955	7995040	BCKDK	16	-0.112556	0.143838	4.83E-05	ATD
rs73530203	7995040	BCKDK	16	0.198508	0.0479232	4.63E-05	Psoriasis 
rs4699052	8102065	BDH2	4	-0.206783	0.0670928	2.14E-06	Testicular germ cell tumor
rs1109748	7940582	BEST1	11	-0.239669	0.0719432	2.86E-07	Phospholipid levels (plasma)
rs10792320	7940582	BEST1	11	-0.196382	0.0732972	3.77E-05	Phospholipid levels (plasma)
rs2280543	7945349	BET1L	11	-0.258444	0.0467475	4.31E-08	Uterine fibroids
rs12434047	7979241	BMP4	14	-0.16549	0.137093	9.59E-05	Economic and political preferences (fairness)
rs11789898	8164995	BRD3	9	0.383935	0.0626232	3.63E-19	Platelet counts
rs6465657	8134454	BRI3	7	0.112461	0.133523	3.98E-06	Prostate cancer
rs9649213	8134454	BRI3	7	-0.225469	0.0473625	2.64E-06	Prostate cancer (gene x gene interaction)
rs4698412	8094228	BST1	4	0.439397	0.164013	2.06E-50	Parkinson's disease
rs1568657	7991057	BTBD1	15	-0.209814	0.0887183	2.11E-06	Kawasaki disease
rs13194053	8117435	BTN3A2	6	0.156319	0.140223	6.42E-05	Schizophrenia
rs603446	7951826	BUD13	11	0.293837	0.0689212	6.21E-11	Triglycerides
rs11825181	7951826	BUD13	11	-0.286623	0.0512158	2.94E-08	Triglycerides-Blood Pressure (TG-BP)
rs7914558	7930170	C10orf32	10	0.21154	0.0478194	1.31E-05	"Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)"
rs7914558	7930170	C10orf32	10	0.21154	0.0478194	1.31E-05	Schizophrenia
rs12220777	7928671	C10orf57	10	-0.244519	0.0469156	2.58E-07	Chronic obstructive pulmonary disease-related biomarkers
rs11009175	7926936	C10orf68	10	-0.272264	0.146905	1.27E-15	Depression (quantitative trait)
rs174529	7948606	C11orf10	11	-0.252493	0.046858	9.63E-08	Crohn's disease 
rs7294919	7966738	C12orf49	12	-0.186342	0.108764	1.55E-06	Brain structure
rs7294919	7966738	C12orf49	12	-0.186342	0.108764	1.55E-06	Hippocampal volume
rs7178909	7991357	C15orf38-AP3S2	15	0.242875	0.135988	2.36E-07	Common traits (Other)
rs2028299	7991357	C15orf38-AP3S2	15	0.523224	0.0365953	7.23E-46	Type 2 diabetes
rs227584	8015946	C17orf65	17	0.369464	0.0991162	2.94E-23	Bone mineral density
rs227584	8015946	C17orf65	17	0.369464	0.0991162	2.94E-23	Bone mineral density (hip)
rs507506	8004293	C17orf81	17	-0.277918	0.0461519	2.53E-09	Adiponectin levels
rs639404	8021286	C18orf54	18	-0.121896	0.151296	4.72E-05	Psoriasis 
rs3817334	7947928	C1QTNF4	11	0.131291	0.151579	8.95E-05	Body mass index
rs372883	8068083	C21orf7	21	0.150658	0.140662	2.29E-09	Pancreatic cancer
rs134882	8073578	C22orf32	22	-0.420176	0.0413444	6.76E-24	Bipolar disorder and schizophrenia
rs13385191	8050608	C2orf43	2	0.294133	0.04578	2.05E-10	Prostate cancer
rs813218	8081241	C3orf26	3	-0.171257	0.15555	9.38E-07	Orofacial clefts
rs2241003	8163839	C5	9	-0.266701	0.0546516	1.75E-08	Rheumatoid arthritis 
rs1048886	8120579	C6orf57	6	0.236109	0.0471358	7.53E-07	Type 2 diabetes
rs10812610	8160531	C9orf72	9	0.235869	0.0795052	9.33E-07	Heart failure
rs1260333	8040843	CAD	2	0.207528	0.0998036	2.00E-06	Triglycerides
rs7068966	7926223	CAMK1D	10	0.196201	0.0847848	9.36E-06	Pulmonary function
rs7068966	7926223	CAMK1D	10	0.196201	0.0847848	9.36E-06	Pulmonary function (interaction)
rs11257655	7926223	CAMK1D	10	-0.242471	0.0470077	3.46E-07	Type 2 diabetes
rs10906115	7926223	CAMK1D	10	0.215874	0.107511	3.24E-05	Type 2 diabetes
rs7512898	7908614	CAMSAP2	1	0.294774	0.10253	2.26E-10	Electrocardiographic conduction measures
rs2292096	7908614	CAMSAP2	1	0.0131923	0.169189	4.53E-05	Epilepsy
rs10781518	8165107	CARD9	9	-0.330104	0.0456603	1.63E-13	Ankylosing spondylitis 
rs10781518	8165107	CARD9	9	-0.330104	0.0456603	1.63E-13	Crohn's disease 
rs10781499	8165107	CARD9	9	-0.230969	0.0473732	1.48E-06	Inflammatory bowel disease
rs10781518	8165107	CARD9	9	-0.330104	0.0456603	1.63E-13	Ulcerative colitis 
rs3814231	7930577	CASP7	10	0.284868	0.0627068	4.62E-10	Vitiligo
rs13016963	8047419	CASP8	2	-0.329668	0.044737	2.28E-13	Melanoma
rs6014724	8063497	CASS4	20	0.2967	0.104596	1.06E-17	Alzheimer's disease
rs9127	8107005	CAST	5	-0.199695	0.115082	4.58E-06	Crohn's disease 
rs27524	8107005	CAST	5	0.251529	0.0593942	3.29E-07	Hodgkin's lymphoma
rs12446550	7994362	CCDC101	16	0.417498	0.0733034	3.77E-27	Crohn's disease 
rs26528	7994362	CCDC101	16	0.408759	0.0563199	1.36E-24	Inflammatory bowel disease
rs750155	7994362	CCDC101	16	0.411991	0.0990564	2.32E-32	Type 1 diabetes 
rs2130392	8098556	CCDC111	4	0.231002	0.0472765	1.40E-06	Kawasaki disease
rs9835332	8080621	CCDC66	3	0.362667	0.102457	1.65E-16	Height
rs169082	8109830	CCDC99	5	-0.205862	0.0477706	2.21E-05	Protein quantitative trait loci
rs11926063	8086600	CCR1	3	-0.258272	0.0804884	4.26E-09	Celiac disease 
rs7616215	8079392	CCR2	3	-0.319058	0.045024	2.32E-12	Behcet's disease
rs7616215	8093294	CCR2	3	-0.317205	0.0450766	3.29E-12	Behcet's disease
rs9990343	8079392	CCR2	3	0.244718	0.0929533	9.90E-11	Brain structure
rs9990343	8093294	CCR2	3	0.199149	0.103486	2.70E-08	Brain structure
rs2201150	8093294	CCR2	3	-0.360019	0.0436181	2.96E-16	Celiac disease 
rs34376347	8093294	CCR2	3	0.316101	0.045138	4.18E-12	Celiac disease 
rs1002979	8089568	CD200R1	3	-0.0689756	0.139055	9.10E-05	Prostate cancer (gene x gene interaction)
rs12036607	7921677	CD244	1	-0.36378	0.0584348	1.07E-15	Crohn's disease 
rs4017459	7921677	CD244	1	0.336105	0.0573207	4.08E-13	Crohn's disease 
rs10512597	8018196	CD300LF	17	-0.293747	0.0672167	2.17E-10	Fibrinogen
rs3865444	8030804	CD33	19	-0.279845	0.067179	3.76E-05	Alzheimer's disease
rs10499859	8133876	CD36	7	-0.184414	0.0630308	5.91E-05	Left ventricular mass
rs6032662	8063156	CD40	20	-0.300007	0.0567227	5.53E-12	Multiple sclerosis 
rs12480534	8063156	CD40	20	-0.0924715	0.142046	2.73E-06	Response to amphetamines
rs6032662	8063156	CD40	20	-0.300007	0.0567227	5.53E-12	Rheumatoid arthritis 
rs2070776	8017511	CD79B	17	0.252738	0.0480375	7.91E-08	Height
rs1558324	7953291	CD9	12	0.271248	0.0463658	7.03E-09	Mean platelet volume
rs4815617	8060675	CDC25B	20	-0.32128	0.0500724	2.16E-10	Asthma
rs13043330	8060675	CDC25B	20	-0.308719	0.0452756	1.50E-11	Visceral adipose tissue adjusted for BMI
rs751837	7981387	CDC42BPB	14	0.235776	0.129606	1.11E-12	Large B-cell lymphoma
rs4487645	8138489	CDCA7L	7	0.427628	0.0913291	4.45E-29	Multiple myeloma
rs4487645	8138489	CDCA7L	7	0.427628	0.0913291	4.45E-29	Multiple myeloma (hyperdiploidy)
rs258322	7997982	CDK10	16	-0.148693	0.160462	1.81E-06	Black vs. red hair color
rs4785763	7997982	CDK10	16	-0.182658	0.107226	4.00E-08	Melanoma
rs258322	7997982	CDK10	16	-0.148693	0.160462	1.81E-06	Melanoma
rs4759375	7967412	CDK2AP1	12	-0.3814	0.0428482	1.14E-18	HDL cholesterol
rs7980687	7967412	CDK2AP1	12	0.30292	0.125067	6.43E-13	Head circumference (infant)
rs1321311	8119088	CDKN1A	6	0.19055	0.0768485	8.64E-06	Colorectal cancer
rs1321311	8119088	CDKN1A	6	0.19055	0.0768485	8.64E-06	Electrocardiographic traits
rs1011970	8160452	CDKN2B	9	0.250231	0.0498907	7.55E-08	Breast cancer
rs766903	7963304	CELA1	12	0.113142	0.129366	2.83E-05	Aging (time to death)
rs11648785	8003553	CENPBD1	16	0.140382	0.141945	9.11E-05	Tanning
rs10992471	8156341	CENPP	9	-0.234965	0.102272	2.29E-09	Visceral adipose tissue/subcutaneous adipose tissue ratio
rs10935120	8082827	CEP63	3	-0.366999	0.0434285	5.70E-17	Height
rs7412746	7919856	CERS2	1	0.201739	0.0532277	2.01E-05	Melanoma
rs11239930	7904883	CHD1L	1	0.305393	0.114208	9.51E-21	AIDS progression
rs4950322	7904883	CHD1L	1	0.149013	0.125476	1.17E-07	Protein quantitative trait loci
rs7274811	8061958	CHMP4B	20	-0.222521	0.0475803	3.97E-06	Height
rs667282	7985213	CHRNA5	15	0.262408	0.0667606	4.34E-08	Smoking behavior
rs950776	7985213	CHRNA5	15	-0.351328	0.0942519	8.19E-22	Sudden cardiac arrest
rs2125623	7987012	CHRNA7	15	0.19246	0.0554297	5.25E-05	Mortality among heart failure patients
rs1371924	8083214	CHST2	3	-0.206893	0.107293	3.25E-09	Tonometry
rs954951	7927649	CISD1	10	0.397788	0.0422743	1.08E-20	Crohn's disease 
rs17367504	7897774	CLCN6	1	-0.228586	0.0473033	1.84E-06	Blood pressure
rs1023252	7897774	CLCN6	1	-0.215221	0.066793	1.25E-05	Natriuretic peptide levels
rs17367504	7897774	CLCN6	1	-0.228586	0.0473033	1.84E-06	Systolic blood pressure
rs507506	8012126	CLDN7	17	-0.216144	0.0475478	7.44E-06	Adiponectin levels
rs9926078	7993223	CLEC16A	16	-0.195332	0.135268	4.11E-06	Type 1 diabetes 
rs10743823	7961069	CLECL1	12	0.708198	0.06031	4.22E-197	Multiple sclerosis 
rs4763839	7961069	CLECL1	12	-0.476162	0.120971	1.57E-43	Type 1 diabetes 
rs4601530	7898988	CLIC4	1	-0.252102	0.0468988	1.04E-07	Height
rs4788080	8000543	CLN3	16	-0.169209	0.0808414	1.89E-05	Crohn's disease 
rs11986414	8144267	CLN8	8	-0.262985	0.0496808	1.42E-08	Gaucher disease severity
rs11986414	8144279	CLN8	8	-0.234345	0.0473182	1.00E-06	Gaucher disease severity
rs10861905	7966089	CMKLR1	12	0.253672	0.0486803	8.82E-08	Erectile dysfunction and prostate cancer treatment
rs7914558	7930194	CNNM2	10	-0.219138	0.047563	5.55E-06	"Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)"
rs7914558	7930194	CNNM2	10	-0.219138	0.047563	5.55E-06	Schizophrenia
rs7779057	8142143	COG5	7	0.230911	0.0473151	1.45E-06	Serum tamsulosin hydrochloride concentration
rs7651039	8085581	COLQ	3	-0.261257	0.0466561	3.04E-08	Coronary heart disease
rs4656955	7921583	COPA	1	0.00913154	0.183282	1.24E-05	Crohn's disease 
rs11867934	8013094	COPS3	17	-0.285755	0.136458	3.06E-15	Diabetic retinopathy 
rs959695	8151993	COX6C	8	0.183933	0.0719185	3.19E-05	Hippocampal atrophy
rs2236164	8065963	CPNE1	20	0.182997	0.0674345	2.59E-05	Height
rs5770917	8077123	CPT1B	22	0.433459	0.0985069	3.91E-29	Narcolepsy
rs10486607	8138805	CPVL	7	0.259162	0.111971	1.46E-10	Diabetes related insulin traits
rs13118159	8093494	CRIPAK	4	-0.20218	0.0479968	3.41E-05	Longevity
rs11605924	7939595	CRY2	11	0.496769	0.0571274	4.08E-40	Fasting glucose-related traits
rs11605924	7939595	CRY2	11	0.496769	0.0571274	4.08E-40	Fasting glucose-related traits (interaction with BMI)
rs3931020	7917037	CRYZ	1	0.615283	0.107874	5.94E-120	Resistin levels 
rs2742234	7927146	CSGALNACT2	10	-0.257219	0.0467959	5.42E-08	Hirschsprung's disease
rs1158167	8065403	CST3	20	-0.183981	0.107938	2.00E-06	Cystatin C
rs17265703	8082058	CSTA	3	0.261242	0.186339	7.86E-14	Phosphorus levels
rs17318596	8029065	CTC-435M10.3	19	-0.64641	0.113394	2.92E-62	Height
rs8192917	7978351	CTSG	14	0.110439	0.160407	2.08E-06	Vitiligo
rs267734	7919815	CTSK	1	0.318366	0.0449295	2.33E-12	Chronic kidney disease
rs7412746	7919815	CTSK	1	0.344428	0.0967437	1.37E-20	Melanoma
rs151361	8067279	CTSZ	20	-0.224978	0.0796695	6.50E-06	Mean platelet volume
rs12830	7933047	CUL2	10	0.203807	0.0478429	2.76E-05	Crohn's disease 
rs11599750	7935730	CWF19L1	10	-0.141847	0.151467	2.94E-09	Height
rs4674257	8048227	CXCR2	2	0.228035	0.0524648	3.09E-06	Ulcerative colitis 
rs7932813	7946292	CYB5R2	11	-0.237208	0.0507699	6.93E-07	Waist circumference
rs13380741	7995552	CYLD	16	0.236202	0.0526638	8.90E-06	Crohn's disease 
rs2303565	8048432	CYP27A1	2	-0.333694	0.164481	2.49E-32	Amyotrophic lateral sclerosis
rs1692120	7940508	DAGLA	11	-0.205461	0.0939861	1.72E-07	Phospholipid levels (plasma)
rs3822412	8110982	DAP	5	0.347204	0.116405	3.97E-28	Ulcerative colitis 
rs420259	7994102	DCTN5	16	-0.324252	0.0969606	4.00E-18	Bipolar disorder
rs3942852	7939738	DDB2	11	-0.317265	0.0451111	3.39E-12	Acute lymphoblastic leukemia (childhood)
rs3817334	7939738	DDB2	11	-0.277024	0.0461625	2.87E-09	Body mass index
rs7932354	7939738	DDB2	11	-0.292186	0.045859	2.88E-10	Bone mineral density
rs7932354	7939738	DDB2	11	-0.292186	0.045859	2.88E-10	Bone mineral density (hip)
rs7944584	7939738	DDB2	11	-0.316768	0.156855	7.98E-16	Fasting glucose-related traits
rs7944584	7939738	DDB2	11	-0.316768	0.156855	7.98E-16	Fasting glucose-related traits (interaction with BMI)
rs7120118	7939738	DDB2	11	0.53974	0.0890323	3.33E-51	HDL cholesterol
rs3136441	7939738	DDB2	11	0.302479	0.0824988	3.27E-12	HDL cholesterol
rs2739330	8071806	DDT	22	-0.454194	0.122866	8.96E-63	Liver enzyme levels (gamma-glutamyl transferase)
rs2739330	8074969	DDT	22	-0.495977	0.0882834	9.85E-59	Liver enzyme levels (gamma-glutamyl transferase)
rs2072183	8139392	DDX56	7	-0.187847	0.0665955	1.69E-05	"Cholesterol, total"
rs2072183	8139392	DDX56	7	-0.187847	0.0665955	1.69E-05	LDL cholesterol
rs494459	7952103	DDX6	11	0.204549	0.0479805	2.72E-05	Height
rs17642632	7923131	DENND1B	1	-0.234688	0.0471637	8.92E-07	Primary biliary cirrhosis 
rs7827290	8148476	DENND3	8	-0.229598	0.0726748	4.09E-06	Bipolar disorder
rs9923856	7982185	DEXI	16	-0.223654	0.0475062	3.42E-06	Atopic dermatitis
rs6028335	8062576	DHX35	20	0.18841	0.0634179	2.27E-05	Alcohol and nictotine co-dependence
rs3099950	8051637	DHX57	2	0.279932	0.0513724	6.00E-08	Amyotrophic lateral sclerosis
rs12042938	7910559	DISC1	1	0.21717	0.0938781	4.91E-09	Neuranatomic and neurocognitive phenotypes
rs4518	8135464	DLD	7	-0.154404	0.131799	1.26E-08	Ulcerative colitis 
rs11599750	7935660	DNMBP	10	-0.191721	0.0481571	9.18E-05	Height
rs1167998	7916669	DOCK7	1	-0.467329	0.0634279	1.10E-38	Lipid metabolism phenotypes
rs1167998	7916669	DOCK7	1	-0.467329	0.0634279	1.10E-38	Triglycerides
rs12130333	7916669	DOCK7	1	0.130945	0.109764	1.78E-05	Triglycerides
rs4938642	7952185	DPAGT1	11	0.133516	0.110056	1.18E-05	Platelet counts
rs255049	8002194	DPEP2	16	-0.245784	0.0840472	1.23E-07	HDL cholesterol
rs255049	7996725	DUS2L	16	-0.452616	0.0950589	9.76E-45	HDL cholesterol
rs6499165	7996725	DUS2L	16	-0.196674	0.0481374	5.90E-05	Metabolic traits
rs11637235	7983594	DUT	15	0.169938	0.161805	2.59E-06	Protein quantitative trait loci
rs9967417	8023228	DYM	18	0.192794	0.0838733	9.05E-05	Height
rs2231884	7949503	EFEMP2	11	0.191144	0.0481173	9.52E-05	Inflammatory bowel disease
rs910316	7975760	EIF2B2	14	-0.314751	0.0923722	4.60E-18	Height
rs62031607	7994415	EIF3C	16	-0.19822	0.108421	1.28E-05	Crohn's disease 
rs62031607	7994415	EIF3C	16	-0.19822	0.108421	1.28E-05	Type 1 diabetes 
rs1555322	8065868	EIF6	20	0.183487	0.0915445	1.04E-06	Attention deficit hyperactivity disorder
rs3777200	8113220	ELL2	5	0.292894	0.0830324	2.43E-11	Serum total protein level
rs710865	7913110	EMC1	1	0.203444	0.0479121	2.93E-05	Brain structure
rs7385804	8141625	EPHB4	7	0.0920652	0.142436	4.88E-05	Hematocrit
rs7385804	8141625	EPHB4	7	0.0920652	0.142436	4.88E-05	Hematological parameters
rs7385804	8141625	EPHB4	7	0.0920652	0.142436	4.88E-05	Iron levels
rs2075671	8141625	EPHB4	7	-0.266178	0.150684	7.63E-14	Other erythrocyte phenotypes
rs13160562	8113250	ERAP1	5	-0.00127082	0.253397	3.29E-14	Alcohol dependence
rs30380	8113250	ERAP1	5	0.711119	0.0288655	1.31E-172	Ankylosing spondylitis 
rs10476696	8113250	ERAP1	5	0.328107	0.101926	6.23E-18	Crohn's disease 
rs27524	8113250	ERAP1	5	0.537988	0.0706193	1.82E-54	Hodgkin's lymphoma
rs27037	8113250	ERAP1	5	0.546187	0.0849692	7.97E-53	Psoriasis 
rs30379	8107044	ERAP2	5	-0.311745	0.068905	3.97E-12	Ankylosing spondylitis 
rs10044354	8107044	ERAP2	5	-0.791986	0.032132	4.55E-310	Crohn's disease 
rs27524	8107044	ERAP2	5	-0.262147	0.0466336	2.79E-08	Hodgkin's lymphoma
rs27037	8107044	ERAP2	5	-0.26152	0.0942458	6.33E-11	Psoriasis 
rs1350666	8095728	EREG	4	-0.219062	0.047495	5.42E-06	Attention deficit hyperactivity disorder
rs6490294	7958819	ERP29	12	0.205204	0.062702	4.87E-05	Mean platelet volume
rs2094871	8068593	ETS2	21	0.172847	0.108925	3.32E-07	Ankylosing spondylitis 
rs2836878	8068593	ETS2	21	0.292149	0.049892	1.28E-10	Ulcerative colitis 
rs12210050	8123524	EXOC2	6	0.235028	0.0526897	9.97E-06	Basal cell carcinoma 
rs12210050	8123524	EXOC2	6	0.235028	0.0526897	9.97E-06	Schizophrenia
rs12210050	8123524	EXOC2	6	0.235028	0.0526897	9.97E-06	Tanning
rs12188164	8104201	EXOC3	5	0.344978	0.0910801	1.63E-14	Cystic fibrosis severity
rs7659604	8097128	EXOSC9	4	-0.143653	0.0963044	3.12E-05	Type 2 diabetes
rs6028	7922174	F5	1	0.261225	0.0782589	7.30E-11	Activated partial thromboplastin time
rs174549	7940565	FADS2	11	-0.302834	0.213625	5.02E-61	Crohn's disease 
rs174601	7940565	FADS2	11	-0.275873	0.152281	5.12E-25	Liver enzyme levels (alkaline phosphatase)
rs968567	7940565	FADS2	11	-0.346065	0.387967	5.83E-108	Rheumatoid arthritis 
rs174479	7940565	FADS2	11	-0.224292	0.0549701	1.76E-06	Sphingolipid levels
rs6725887	8047565	FAM117B	2	0.234284	0.0471685	9.34E-07	Coronary heart disease
rs6725887	8047565	FAM117B	2	0.234284	0.0471685	9.34E-07	Myocardial infarction (early onset)
rs11220462	7945058	FAM118B	11	0.078631	0.136803	6.27E-05	"Cholesterol, total"
rs11220462	7945058	FAM118B	11	0.078631	0.136803	6.27E-05	LDL cholesterol
rs12470505	8048468	FAM134A	2	-0.199526	0.047986	4.32E-05	Height
rs4693089	8101489	FAM175A	4	0.283858	0.0945895	9.46E-13	Menopause (age at onset)
rs494453	7918552	FAM212B	1	-0.233045	0.067291	4.34E-06	Osteoporosis
rs7544646	7897119	FAM213B	1	0.255538	0.0468266	6.66E-08	Ulcerative colitis 
rs2292354	7958666	FAM216A	12	-0.251394	0.14017	6.93E-14	Metabolic syndrome
rs4441471	8050427	FAM49A	2	-0.279925	0.0461864	2.00E-09	Orofacial clefts
rs7179456	7983940	FAM63B	15	0.287915	0.0553803	4.29E-10	Asperger disorder
rs12694997	8049847	FARP2	2	-0.358222	0.048689	3.27E-13	Height
rs2234978	7929032	FAS	10	-0.192624	0.112105	3.42E-09	Immunoglobulin A 
rs10057405	8113800	FBN2	5	-0.237107	0.105866	1.90E-07	Temperament
rs7294919	7959039	FBXW8	12	-0.727425	0.0527433	1.67E-200	Brain structure
rs7294919	7959039	FBXW8	12	-0.727425	0.0527433	1.67E-200	Hippocampal volume
rs11672983	8031374	FCAR	19	-0.279527	0.0671743	3.83E-05	Inflammatory bowel disease
rs2251746	7906443	FCER1A	1	-0.50197	0.135669	4.05E-90	IgE levels 
rs12075	7906443	FCER1A	1	-0.287988	0.0680032	2.87E-11	Inflammatory biomarkers
rs3845624	7906443	FCER1A	1	0.26778	0.0754906	3.74E-11	Inflammatory biomarkers
rs12075	7906443	FCER1A	1	-0.287988	0.0680032	2.87E-11	Monocyte chemoattractant protein-1 
rs12075	7906443	FCER1A	1	-0.287988	0.0680032	2.87E-11	Obesity-related traits
rs12075	7906443	FCER1A	1	-0.287988	0.0680032	2.87E-11	White blood cell count
rs1801274	7906757	FCGR2A	1	0.258268	0.0466066	3.96E-08	Ankylosing spondylitis 
rs1801274	7906757	FCGR2A	1	0.258268	0.0466066	3.96E-08	Inflammatory bowel disease
rs1801274	7906757	FCGR2A	1	0.258268	0.0466066	3.96E-08	Kawasaki disease
rs1801274	7906757	FCGR2A	1	0.258268	0.0466066	3.96E-08	Ulcerative colitis 
rs3748682	7915147	FHL3	1	0.36411	0.0434419	1.02E-16	Hypothyroidism
rs2212361	7943226	FOLR4	11	0.197772	0.111669	2.20E-05	Attention deficit hyperactivity disorder symptoms (interaction)
rs6995402	8153828	FOXH1	8	0.147511	0.14475	9.75E-05	Platelet counts
rs6591182	7941260	FRMD8	11	-0.222859	0.0475902	3.85E-06	Non-alcoholic fatty liver disease histology (lobular)
rs7147624	7975136	FUT8	14	-0.396108	0.0594787	2.11E-16	Chronic obstructive pulmonary disease-related biomarkers
rs10483776	7975136	FUT8	14	0.344615	0.0442071	1.18E-14	N-glycan levels
rs4322600	7980580	GALC	14	-0.205155	0.0479579	2.55E-05	Breast cancer
rs4240672	8144643	GATA4	8	0.209429	0.0576361	3.19E-05	Systemic lupus erythematosus 
rs10187424	8053429	GGCX	2	-0.186285	0.178854	9.75E-15	Prostate cancer
rs2073398	8074716	GGT1	22	0.162196	0.125974	8.58E-08	Liver enzyme levels (gamma-glutamyl transferase)
rs2073398	8071927	GGT1	22	0.135264	0.136824	4.43E-07	Liver enzyme levels (gamma-glutamyl transferase)
rs2075671	8141595	GIGYF1	7	0.216972	0.0915252	7.50E-09	Other erythrocyte phenotypes
rs2590838	8080419	GNL3	3	0.253347	0.0687273	1.55E-08	Adiponectin levels
rs2239547	8080419	GNL3	3	0.299975	0.0718785	2.84E-10	Schizophrenia
rs12600277	8001764	GOT2	16	-0.229164	0.169517	4.60E-22	Aortic root size
rs2255141	7936322	GPAM	10	0.18698	0.0751846	1.33E-05	"Cholesterol, total"
rs2255141	7936322	GPAM	10	0.18698	0.0751846	1.33E-05	LDL cholesterol
rs61700947	8048249	GPBAR1	2	0.263118	0.0755851	9.67E-10	Ulcerative colitis 
rs7601713	8045816	GPD2	2	0.207207	0.0680948	4.54E-06	QT interval
rs2292354	7966321	GPN3	12	-0.136626	0.144551	5.91E-07	Metabolic syndrome
rs17300741	7940959	GPR137	11	-0.186811	0.0973515	4.91E-05	Uric acid levels
rs34236350	8049722	GPR35	2	0.355019	0.0878782	3.16E-16	Ankylosing spondylitis 
rs4676410	8049722	GPR35	2	0.279444	0.0855248	5.56E-09	Sclerosing cholangitis and ulcerative colitis (combined)
rs34236350	8049722	GPR35	2	0.355019	0.0878782	3.16E-16	Ulcerative colitis 
rs4676406	8049722	GPR35	2	-0.0138717	0.231793	4.65E-10	Ulcerative colitis 
rs10876550	7963770	GPR84	12	-0.308716	0.0453402	1.60E-11	Mean platelet volume
rs11971186	8142718	GRM8	7	0.0241543	0.176652	3.23E-05	Chemerin levels
rs2739330	8074980	GSTT1	22	-0.206639	0.184438	6.26E-22	Liver enzyme levels (gamma-glutamyl transferase)
rs2403254	7938762	GTF2H1	11	-0.114805	0.181538	7.52E-12	Metabolic traits
rs6719977	8051799	HAAO	2	-0.211692	0.0916646	3.74E-08	Hyperactive-impulsive symptoms
rs2677744	7991401	HDDC3	15	-0.257483	0.0521045	9.43E-07	Attention deficit hyperactivity disorder
rs4785204	7995456	HEATR3	16	0.245751	0.0620472	9.01E-07	Esophageal cancer (squamous cell)
rs10993160	8156538	HIATL1	9	-0.473004	0.168115	9.85E-53	Body mass index
rs10993160	8162645	HIATL1	9	-0.448549	0.127601	1.94E-32	Body mass index
rs12153855	8125461	HLA-DQB1	6	0.18485	0.0632996	8.86E-05	Age-related macular degeneration
rs61354389	8138708	HOXA1	7	-0.274947	0.046332	4.28E-09	Type 1 diabetes 
rs2326017	8016438	HOXB2	17	0.131062	0.118373	3.68E-06	Body mass index (non-asthmatics)
rs2326017	8016438	HOXB2	17	0.131062	0.118373	3.68E-06	Cognitive performance
rs16973500	7997188	HP	16	0.319103	0.0449797	2.19E-12	Attention deficit hyperactivity disorder and conduct disorder
rs2000999	7997188	HP	16	0.459392	0.0396406	1.23E-30	"Cholesterol, total"
rs16971384	7997188	HP	16	-0.245428	0.12375	2.90E-08	Coronary heart disease
rs2000999	7997188	HP	16	0.459392	0.0396406	1.23E-30	Haptoglobin levels
rs2000999	7997188	HP	16	0.459392	0.0396406	1.23E-30	LDL cholesterol
rs7186908	7997188	HP	16	0.34836	0.0440868	5.10E-15	Liver enzyme levels (alkaline phosphatase)
rs16973500	7997192	HPR	16	0.281031	0.0461375	1.66E-09	Attention deficit hyperactivity disorder and conduct disorder
rs2000999	7997192	HPR	16	0.40275	0.0455058	1.20E-21	"Cholesterol, total"
rs2000999	7997192	HPR	16	0.40275	0.0455058	1.20E-21	Haptoglobin levels
rs2000999	7997192	HPR	16	0.40275	0.0455058	1.20E-21	LDL cholesterol
rs7186908	7997192	HPR	16	0.325551	0.044834	6.61E-13	Liver enzyme levels (alkaline phosphatase)
rs7294919	7966746	HRK	12	-0.359097	0.0436596	3.75E-16	Brain structure
rs7294919	7966746	HRK	12	-0.359097	0.0436596	3.75E-16	Hippocampal volume
rs281437	8025612	ICAM1	19	-0.686999	0.0907746	4.09E-94	Soluble ICAM-1
rs762421	8070720	ICOSLG	21	0.263119	0.0464745	2.19E-08	Ankylosing spondylitis 
rs762421	8070720	ICOSLG	21	0.263119	0.0464745	2.19E-08	Crohn's disease 
rs762421	8070720	ICOSLG	21	0.263119	0.0464745	2.19E-08	Ulcerative colitis 
rs1800871	7923907	IL10	1	-0.397922	0.0422138	9.22E-21	Behcet's disease
rs3748682	7915101	INPP5B	1	0.272032	0.0902483	2.05E-11	Hypothyroidism
rs13180	7985166	IREB2	15	0.208948	0.0745397	4.57E-07	Chronic obstructive pulmonary disease
rs4963128	7945462	IRF7	11	0.199763	0.0558104	2.84E-05	Systemic lupus erythematosus 
rs12988934	8046695	ITGA4	2	0.455438	0.0398657	8.18E-30	White blood cell types
rs12621278	8046380	ITGA6	2	-0.282784	0.0542549	2.27E-07	Prostate cancer
rs267567	8078619	ITGA9	3	0.356562	0.0437013	6.44E-16	PR interval
rs57348955	7995128	ITGAX	16	-0.280497	0.129237	3.02E-15	ATD
rs3925075	7995128	ITGAX	16	-0.323729	0.13468	3.98E-18	IgA nephropathy
rs2590838	8088020	ITIH4	3	-0.20611	0.123208	2.11E-09	Adiponectin levels
rs2336725	8088020	ITIH4	3	-0.107823	0.127578	3.50E-05	Height
rs2239547	8088020	ITIH4	3	-0.46568	0.0488904	1.32E-33	Schizophrenia
rs10518693	7982723	IVD	15	-0.343667	0.0586028	3.96E-16	Metabolic traits
rs4468641	7995055	KAT8	16	-0.213149	0.0626916	3.40E-05	Psoriasis 
rs2904524	7957126	KCNMB4	12	-0.232695	0.0472653	1.16E-06	Amyotrophic lateral sclerosis (age of onset)
rs801193	8133167	KCTD7	7	0.280431	0.0461217	1.78E-09	Aortic root size
rs17418283	8113097	KIAA0825	5	0.20118	0.101189	2.43E-08	Bipolar disorder
rs17418283	8113103	KIAA0825	5	0.160273	0.101392	2.88E-06	Bipolar disorder
rs17418283	8113113	KIAA0825	5	0.183669	0.0742132	1.16E-05	Bipolar disorder
rs740363	7936529	KIAA1598	10	0.341619	0.0443041	2.27E-14	Heart failure
rs7078160	7936529	KIAA1598	10	-0.405168	0.0845507	9.21E-30	Orofacial clefts
rs17396340	7897561	KIF1B	1	-0.527741	0.101433	5.55E-52	Mean platelet volume
rs9543325	7969414	KLF5	13	0.541039	0.0385163	7.14E-51	Pancreatic cancer
rs1886449	7969414	KLF5	13	-0.252577	0.141053	1.31E-10	Pancreatic cancer
rs11647936	7997626	KLHL36	16	0.154249	0.137513	5.11E-05	Waist circumference
rs11071720	7984103	LACTB	15	-0.231525	0.0473662	1.39E-06	Mean platelet volume
rs2652822	7984103	LACTB	15	-0.341034	0.0442243	2.26E-14	Metabolic traits
rs2074518	8006479	LIG3	17	0.13593	0.116568	6.89E-06	QT interval
rs103294	8039226	LILRA3	19	0.583567	0.124917	1.56E-39	Prostate cancer
rs1412444	7934920	LIPA	10	-0.729488	0.0393223	3.78E-206	Coronary heart disease
rs8049607	7999468	LITAF	16	0.244176	0.0537406	4.35E-07	QT interval
rs10863936	7924107	LPGAT1	1	0.211439	0.0477078	1.26E-05	Height
rs183211	8016245	LRRC37A	17	0.255933	0.134804	3.12E-18	Ovarian cancer in BRCA1 mutation carriers 
rs199533	8016245	LRRC37A	17	0.481516	0.0747886	4.70E-33	Parkinson's disease
rs853308	8152962	LRRC6	8	-0.358882	0.0437139	4.25E-16	Vitiligo
rs12827541	7954810	LRRK2	12	0.328178	0.103608	1.47E-15	Parkinson's disease
rs6968385	8135488	LRRN3	7	0.0553848	0.155348	8.66E-06	Attention deficit hyperactivity disorder (time to onset)
rs907611	7905028	LSP1	11	-0.535762	0.0819319	8.31E-66	Inflammatory bowel disease
rs907611	7937735	LSP1	11	-0.511346	0.0965144	2.23E-59	Inflammatory bowel disease
rs907611	7968126	LSP1	11	-0.527439	0.0675981	1.83E-53	Inflammatory bowel disease
rs907611	7905028	LSP1	11	-0.535762	0.0819319	8.31E-66	Ulcerative colitis 
rs7974988	7953321	LTBR	12	0.178808	0.181353	1.03E-07	Ankylosing spondylitis 
rs2294008	8153346	LYNX1	8	0.221436	0.0475361	4.35E-06	Duodenal ulcer 
rs7944584	7939767	MADD	11	-0.109252	0.191354	2.65E-06	Fasting glucose-related traits
rs7120118	7939767	MADD	11	0.308004	0.149951	1.62E-12	HDL cholesterol
rs13118159	8093462	MAEA	4	-0.17703	0.0810681	1.19E-05	Longevity
rs2902940	8066266	MAFB	20	-0.278581	0.0473258	1.74E-09	"Cholesterol, total"
rs2902940	8066266	MAFB	20	-0.278581	0.0473258	1.74E-09	LDL cholesterol
rs4886707	7990457	MAN2C1	15	-0.591599	0.0328658	7.67E-72	Height
rs4014195	7949454	MAP3K11	11	-0.223182	0.0474811	3.54E-06	Chronic kidney disease
rs6733839	8054995	MAP3K2	2	0.156654	0.0897827	3.11E-05	Alzheimer's disease
rs2665838	8009183	MAP3K3	17	-0.198234	0.071482	3.41E-06	Height
rs319690	8086842	MAP4	3	0.205423	0.0477692	2.31E-05	Blood pressure
rs6879260	8116402	MAPK9	5	-0.235003	0.0605914	2.01E-06	Height
rs13088462	8080013	MAPKAPK3	3	0.238819	0.0525995	6.87E-06	Height
rs618160	7940798	MARK2	11	0.211542	0.0477081	1.25E-05	Crohn's disease 
rs1318867	8047243	MARS2	2	-0.303289	0.0454922	4.18E-11	Crohn's disease 
rs7584099	8045604	MBD5	2	0.201822	0.0519177	3.12E-05	Response to statin therapy
rs190982	8113039	MEF2C	5	-0.190544	0.0489122	2.72E-06	Alzheimer's disease
rs55792453	8044391	MERTK	2	0.435289	0.0406627	2.35E-26	Multiple sclerosis 
rs10783847	7956631	METTL21B	12	-0.53458	0.0359853	2.12E-49	Multiple sclerosis 
rs10783847	7956631	METTL21B	12	-0.53458	0.0359853	2.12E-49	Type 1 diabetes 
rs2336384	7897824	MFN2	1	0.158025	0.173929	3.50E-11	Platelet counts
rs7578035	8054135	MGAT4A	2	-0.167733	0.122744	5.61E-08	Bipolar disorder
rs477692	7931379	MGMT	10	-0.178546	0.0661224	5.90E-05	Response to temozolomide
rs1076540	8074286	MICAL3	22	0.158814	0.0833187	4.69E-05	Liver enzyme levels (gamma-glutamyl transferase)
rs2130392	8103932	MLF1IP	4	-0.264744	0.0646097	1.74E-09	Kawasaki disease
rs26868	7992552	MLST8	16	-0.214913	0.113223	4.59E-07	Height
rs7385804	8134880	MOSPD3	7	-0.2946	0.0492251	1.04E-10	Hematocrit
rs7385804	8134880	MOSPD3	7	-0.2946	0.0492251	1.04E-10	Hematological parameters
rs7385804	8134880	MOSPD3	7	-0.2946	0.0492251	1.04E-10	Iron levels
rs2075671	8134880	MOSPD3	7	0.262113	0.103788	6.21E-14	Other erythrocyte phenotypes
rs1727307	7967386	MPHOSPH9	12	0.196811	0.0743257	9.59E-06	Platelet counts
rs6495122	7984922	MPI	15	-0.194942	0.0754875	2.16E-06	Caffeine consumption
rs7176022	7984922	MPI	15	-0.206039	0.0478719	2.27E-05	Celiac disease 
rs6495122	7984922	MPI	15	-0.194942	0.0754875	2.16E-06	Coffee consumption
rs6495122	7984922	MPI	15	-0.194942	0.0754875	2.16E-06	Diastolic blood pressure
rs11867934	8005235	MPRIP	17	0.163936	0.108273	1.64E-06	Diabetic retinopathy 
rs17122021	7952046	MPZL2	11	-0.269198	0.046467	9.80E-09	Pain
rs17602572	7940237	MS4A4A	11	0.302049	0.0921264	2.19E-15	Alzheimer's disease
rs600550	7940237	MS4A4A	11	-0.348856	0.0615532	1.61E-14	Lipoprotein-associated phospholipase A2 activity and mass
rs600550	7948455	MS4A6A	11	-0.198173	0.122279	2.60E-05	Lipoprotein-associated phospholipase A2 activity and mass
rs4636294	8154635	MTAP	9	0.438157	0.0405946	9.08E-27	Cutaneous nevi
rs3817334	7947934	MTCH2	11	0.146012	0.0977632	5.82E-05	Body mass index
rs1152591	7975045	MTHFD1	14	0.169051	0.117434	9.10E-08	Atrial fibrillation
rs17367504	7912496	MTHFR	1	-0.230965	0.047403	1.50E-06	Blood pressure
rs1801133	7912496	MTHFR	1	0.139241	0.111306	1.03E-05	Homocysteine levels
rs1023252	7912496	MTHFR	1	-0.211228	0.0476627	1.26E-05	Natriuretic peptide levels
rs17367504	7912496	MTHFR	1	-0.230965	0.047403	1.50E-06	Systolic blood pressure
rs7336332	7970704	MTIF3	13	0.0507944	0.192244	1.94E-06	Weight
rs7819412	8144600	MTMR9	8	-0.201747	0.0478599	3.36E-05	Triglycerides
rs2106595	8135688	NAA38	7	-0.0881308	0.152566	5.39E-07	Smoking behavior
rs2273	8101086	NAAA	4	-0.252026	0.0792395	3.83E-10	Longevity
rs2950390	7964262	NACA	12	-0.275556	0.104087	2.86E-10	Mean platelet volume
rs12367822	7964262	NACA	12	-0.244091	0.0554084	3.08E-07	Platelet aggregation
rs116849218	7964262	NACA	12	-0.22677	0.0558913	6.00E-05	Psoriasis 
rs2290416	8153430	NAPRT1	8	0.335202	0.0864637	1.55E-17	Attention deficit hyperactivity disorder
rs4654748	7898679	NBPF3	1	0.464685	0.0580786	4.62E-36	Folate pathway vitamin levels
rs4821544	8072744	NCF4	22	0.273579	0.0914622	1.76E-12	Atopic dermatitis
rs730566	8087182	NCKIPSD	3	0.121749	0.138405	3.85E-05	Prion diseases
rs11917431	8087182	NCKIPSD	3	-0.186041	0.100402	1.53E-05	Ulcerative colitis 
rs6863411	8108861	NDFIP1	5	0.253705	0.053723	4.63E-08	Inflammatory bowel disease
rs2227564	7934459	NDST2	10	-0.174189	0.119357	1.07E-08	Inflammatory bowel disease
rs2568958	7916986	NEGR1	1	-0.381991	0.1387	6.06E-45	Body mass index
rs2568958	7916986	NEGR1	1	-0.381991	0.1387	6.06E-45	Obesity
rs2568958	7916986	NEGR1	1	-0.381991	0.1387	6.06E-45	Weight
rs4660456	7900468	NFYC	1	0.361413	0.0814427	8.86E-17	Platelet counts
rs821470	7995926	NLRC5	16	-0.221132	0.0971042	1.85E-09	Bipolar disorder and schizophrenia
rs4605213	8008517	NME1	17	-0.1971	0.0882796	8.61E-06	Height
rs2718058	8132349	NME8	7	0.180653	0.0982334	1.11E-06	Alzheimer's disease
rs12103	7911359	NOC2L	1	-0.211159	0.0751411	2.50E-05	Inflammatory bowel disease
rs62027635	7995539	NOD2	16	-0.219918	0.0603981	2.60E-05	Crohn's disease 
rs9302752	7995539	NOD2	16	-0.504069	0.0531939	2.34E-41	Leprosy
rs11212617	7951497	NPAT	11	0.284001	0.0578363	3.38E-09	Response to metformin
rs862034	7980146	NPC2	14	-0.217619	0.0580051	1.18E-05	Height
rs7120118	7939751	NR1H3	11	0.257821	0.0654497	7.54E-08	HDL cholesterol
rs472402	8110894	NSUN2	5	-0.226343	0.0979525	1.49E-05	Response to amphetamines
rs1566039	8110894	NSUN2	5	-0.136024	0.138964	4.61E-06	Sphingolipid levels
rs1330	7938687	NUCB2	11	0.216546	0.0476979	7.65E-06	Height
rs863725	7923798	NUCKS1	1	0.248859	0.0657912	1.85E-07	Parkinson's disease
rs216345	8154885	NUDT2	9	-0.306147	0.0454081	2.52E-11	Bipolar disorder
rs12224672	7947991	NUP160	11	-0.420393	0.0413629	6.71E-24	Alzheimer's disease
rs3817334	7947991	NUP160	11	0.198558	0.0744879	2.41E-06	Body mass index
rs2293579	7947991	NUP160	11	-0.270102	0.0638545	2.01E-08	Serum albumin level
rs3814219	7936134	OBFC1	10	-0.245304	0.060155	4.67E-07	Endothelial function traits
rs2279008	8026687	OCEL1	19	-0.197153	0.262499	9.44E-06	Height
rs2108622	8026483	OR10H2	19	-0.0214607	0.322494	4.93E-05	Acenocoumarol maintenance dosage
rs2108622	8026483	OR10H2	19	-0.0214607	0.322494	4.93E-05	Metabolite levels
rs2108622	8026483	OR10H2	19	-0.0214607	0.322494	4.93E-05	Response to Vitamin E supplementation
rs2108622	8026483	OR10H2	19	-0.0214607	0.322494	4.93E-05	Vitamin E levels
rs2108622	8026483	OR10H2	19	-0.0214607	0.322494	4.93E-05	Warfarin maintenance dose
rs2284746	7912937	PADI2	1	-0.421648	0.0639636	1.50E-26	Height
rs2284746	7912937	PADI2	1	-0.421648	0.0639636	1.50E-26	Pulmonary function
rs2284746	7912937	PADI2	1	-0.421648	0.0639636	1.50E-26	Pulmonary function (interaction)
rs12216812	8151512	PAG1	8	0.260187	0.0520118	6.89E-07	Myopia (pathological)
rs79718165	7964089	PAN2	12	-0.225432	0.0559939	6.86E-05	Psoriasis 
rs11136341	8153609	PARP10	8	0.18589	0.0675509	2.96E-05	"Cholesterol, total"
rs11136341	8153609	PARP10	8	0.18589	0.0675509	2.96E-05	LDL cholesterol
rs9581094	7970602	PARP4	13	0.371601	0.0481797	2.24E-14	Sudden cardiac arrest
rs282544	8105191	PARP8	5	0.322447	0.0924179	1.11E-11	Myopia (pathological)
rs11123170	8054740	PAX8	2	0.341076	0.0508657	3.51E-14	Renal function-related traits (BUN)
rs4234853	8093398	PCGF3	4	-0.165281	0.109048	1.95E-05	Hemostatic factors and hematological phenotypes
rs79713586	8093398	PCGF3	4	0.418098	0.0704987	2.81E-28	Parkinson's disease
rs6656401	7909285	PFKFB2	1	0.211424	0.0786369	4.31E-06	Alzheimer's disease
rs2031532	7969129	PHF11	13	-0.251152	0.0863355	1.24E-10	Cardiac hypertrophy
rs1008382	8163807	PHF19	9	-0.235631	0.047303	0.000000868	Rheumatoid arthritis 
rs4788815	8002571	PHLPP2	16	0.230218	0.0655072	1.47E-07	Metabolite levels
rs1561570	7932094	PHYH	10	-0.318067	0.0604068	1.76E-12	Paget's disease
rs2576037	8023133	PIAS2	18	0.202454	0.11567	8.55E-08	Personality dimensions
rs1003719	8070257	PIGP	21	0.250376	0.0718742	2.71E-08	Eye color traits
rs4356203	7946815	PIK3C2A	11	-0.251403	0.0468621	1.12E-07	Schizophrenia
rs10033900	8102321	PLA2G12A	4	0.203831	0.0523311	2.56E-05	Age-related macular degeneration
rs10033900	8102321	PLA2G12A	4	0.203831	0.0523311	2.56E-05	Age-related macular degeneration (CNV)
rs10033900	8102321	PLA2G12A	4	0.203831	0.0523311	2.56E-05	Age-related macular degeneration (GA)
rs1869901	7987475	PLCB2	15	-0.209151	0.0964666	9.78E-08	Schizophrenia
rs1579695	8047248	PLCL1	2	0.524684	0.0491258	1.21E-45	Crohn's disease 
rs7595412	8047248	PLCL1	2	0.189615	0.208895	6.86E-10	Hip bone size
rs700651	8047248	PLCL1	2	0.201094	0.0515801	3.38E-05	Intracranial aneurysm
rs2289688	8042391	PLEK	2	-0.127238	0.180924	3.83E-07	Celiac disease 
rs4392868	8147439	PLEKHF2	8	0.282515	0.0512372	4.38E-08	Radiation response
rs4810479	8066619	PLTP	20	0.214758	0.0476762	9.01E-06	Metabolite levels
rs1380181	8012896	PMP22	17	0.216684	0.0650691	1.13E-06	QT interval
rs2382817	8048257	PNKD	2	-0.280665	0.189779	4.18E-24	Inflammatory bowel disease
rs2230054	8048257	PNKD	2	0.234625	0.0472044	9.18E-07	Ulcerative colitis 
rs10498345	7974066	PNN	14	-0.117762	0.270449	2.55E-05	Coronary spasm
rs782590	8052331	PNPT1	2	0.199133	0.0480325	4.56E-05	Metabolic syndrome
rs694650	8021275	POLI	18	-0.0488143	0.205793	1.10E-08	Psoriasis 
rs6983267	8148315	POU5F1B	8	0.193302	0.0799685	9.69E-05	Colorectal cancer
rs6983267	8148315	POU5F1B	8	0.193302	0.0799685	9.69E-05	Prostate cancer
rs3729931	8077899	PPARG	3	0.274146	0.0473225	4.01E-09	Cardiac hypertrophy
rs6766510	8077899	PPARG	3	-0.229493	0.158773	2.00E-09	Prostate cancer (gene x gene interaction)
rs4768412	7954940	PPHLN1	12	-0.230935	0.0936832	2.64E-09	ATD
rs8396	8103437	PPID	4	0.422488	0.0795289	2.47E-31	Metabolic traits
rs8396	8103437	PPID	4	0.422488	0.0795289	2.47E-31	Metabolite levels
rs6716724	8040278	PQLC3	2	-0.195344	0.0480166	6.36E-05	Sudden cardiac arrest
rs6063312	8066848	PREX1	20	0.243881	0.0591909	1.12E-07	Tonometry
rs2950390	7964271	PRIM1	12	-0.244609	0.0926018	2.30E-06	Mean platelet volume
rs2277339	7964271	PRIM1	12	0.286544	0.045958	6.83E-10	Menopause (age at onset)
rs12367822	7964271	PRIM1	12	-0.206485	0.0594868	4.23E-05	Platelet aggregation
rs11171747	7964271	PRIM1	12	-0.19157	0.0919553	7.50E-05	Systemic sclerosis 
rs7404095	7994131	PRKCB	16	-0.64752	0.0367836	2.01E-107	Inflammatory bowel disease
rs4968031	7994131	PRKCB	16	0.0310653	0.270984	1.92E-05	Platelet counts
rs4118325	7903457	PRMT6	1	-0.220354	0.0800764	2.25E-06	AIDS
rs17496332	7903457	PRMT6	1	0.362792	0.134507	1.13E-21	Sex hormone-binding globulin levels
rs4924935	8005512	PRPSAP2	17	-0.203309	0.0977386	5.45E-08	Pancreatic cancer
rs11123170	8044584	PSD4	2	-0.0376808	0.163067	1.10E-05	Renal function-related traits (BUN)
rs599839	7918300	PSRC1	1	0.219924	0.0914446	4.19E-09	Coronary heart disease
rs599839	7918300	PSRC1	1	0.219924	0.0914446	4.19E-09	LDL cholesterol
rs599839	7918300	PSRC1	1	0.219924	0.0914446	4.19E-09	Lipoprotein-associated phospholipase A2 activity and mass
rs2548145	8105067	PTGER4	5	-0.200654	0.0478593	3.71E-05	Alcoholism (alcohol use disorder factor score)
rs28834970	8145490	PTK2B	8	-0.532647	0.0360644	7.59E-49	Alzheimer's disease
rs7395662	7939839	PTPRJ	11	0.206763	0.0478103	2.06E-05	HDL cholesterol
rs7608910	8052418	PUS10	2	0.181463	0.0969891	1.95E-06	Celiac disease 
rs6754585	8052418	PUS10	2	0.191926	0.099947	2.29E-07	Crohn's disease 
rs7608910	8052418	PUS10	2	0.181463	0.0969891	1.95E-06	Ulcerative colitis 
rs11130633	8080781	PXK	3	0.231841	0.106256	3.69E-11	Systemic lupus erythematosus 
rs823144	7923812	RAB7L1	1	-0.409595	0.0418016	2.57E-22	Parkinson's disease
rs2302189	8008754	RAD51C	17	0.257054	0.0466916	5.05E-08	Dental caries
rs2742234	7933149	RASGEF1A	10	0.212425	0.094065	2.81E-06	Hirschsprung's disease
rs505802	7949104	RASGRP2	11	0.197947	0.0599539	2.12E-05	Uric acid levels
rs11130248	8087640	RASSF1	3	0.359948	0.0636204	2.13E-08	Keloid
rs6762477	8079842	RBM6	3	-0.273031	0.101159	1.53E-14	Menarche (age at onset)
rs1873625	8079842	RBM6	3	-0.13401	0.123984	8.11E-06	Ulcerative colitis 
rs2657888	7956261	RBMS2	12	0.260603	0.0600881	1.20E-07	Adiponectin levels
rs4908760	7912166	RERE	1	-0.208492	0.0684492	6.10E-06	Vitiligo
rs2816316	7908388	RGS1	1	0.511212	0.121932	2.70E-73	Celiac disease 
rs2816316	7908388	RGS1	1	0.511212	0.121932	2.70E-73	Multiple sclerosis 
rs2816316	7908388	RGS1	1	0.511212	0.121932	2.70E-73	Type 1 diabetes 
rs12654812	8110327	RGS14	5	-0.221402	0.0475976	4.49E-06	Inflammatory bowel disease
rs12654812	8110327	RGS14	5	-0.221402	0.0475976	4.49E-06	Renal function-related traits (eGRFcrea)
rs12654812	8110327	RGS14	5	-0.221402	0.0475976	4.49E-06	Renal function-related traits (sCR)
rs3820928	8048772	RHBDD1	2	-0.177436	0.0842056	4.69E-06	Pulmonary function
rs140499	8071532	RIMBP3B	22	0.248815	0.0469482	1.61E-07	Celiac disease 
rs140499	8071532	RIMBP3B	22	0.248815	0.0469482	1.61E-07	Crohn's disease 
rs140499	8071532	RIMBP3B	22	0.248815	0.0469482	1.61E-07	Psoriasis 
rs5754217	8071532	RIMBP3B	22	0.224625	0.0474278	2.97E-06	Red blood cell traits
rs2239824	8130768	RNASET2	6	0.572	0.033212	6.47E-20	Rheumatoid arthritis 
rs4809768	8063369	RNF114	20	0.207122	0.0479267	2.09E-05	Psoriasis 
rs17826255	8006229	RNF135	17	-0.116933	0.176101	2.58E-07	Myopia (pathological)
rs1473247	8115562	RNF145	5	0.217947	0.0656535	5.72E-07	Mean platelet volume
rs12153855	8178188	RNF5	6	-0.348666	0.07607	1.00E-13	Age-related macular degeneration
rs12153855	8150356	RNF5	6	-0.316252	0.0941442	2.75E-11	Age-related macular degeneration
rs12153855	8118535	RNF5	6	-0.305456	0.0810826	4.10E-10	Age-related macular degeneration
rs11966200	8178188	RNF5	6	-0.196543	0.0869363	8.61E-05	Vitiligo
rs4963128	7945420	RNH1	11	-0.219637	0.057768	1.39E-06	Systemic lupus erythematosus 
rs4130590	8047635	RPL12	9	-0.233001	0.124596	9.61E-14	Bipolar disorder
rs4130590	8063473	RPL12	9	-0.213911	0.112444	1.00E-10	Bipolar disorder
rs694739	7941039	RPS6KA4	11	0.224749	0.105207	7.88E-11	Alopecia areata
rs12575642	7941039	RPS6KA4	11	0.24899	0.104648	9.05E-08	Attention deficit hyperactivity disorder
rs499425	7941039	RPS6KA4	11	0.137409	0.20506	5.32E-16	Crohn's disease 
rs477895	7941039	RPS6KA4	11	0.188817	0.111603	1.48E-05	Mean platelet volume
rs72926005	7941039	RPS6KA4	11	0.259757	0.125262	5.14E-17	Psoriasis 
rs611744	8152314	RSPO2	8	0.191476	0.115427	5.10E-05	Dupuytren's disease
rs2832077	8069744	RWDD2B	21	-0.203637	0.0805462	8.50E-06	Cognitive test performance
rs10935120	8090840	RYK	3	0.185977	0.100484	5.64E-05	Height
rs11672983	8039520	SBK2	19	0.279087	0.0671995	3.97E-05	Inflammatory bowel disease
rs140522	8077099	SCO2	22	-0.285234	0.0507431	6.64E-10	Red blood cell traits
rs2743403	8066513	SDC4	20	-0.202026	0.0821896	9.67E-06	Psoriasis 
rs3812575	8165156	SDCCAG3	9	0.331607	0.107695	5.85E-16	Ankylosing spondylitis 
rs3812575	8165156	SDCCAG3	9	0.331607	0.107695	5.85E-16	Crohn's disease 
rs3812575	8165156	SDCCAG3	9	0.331607	0.107695	5.85E-16	Ulcerative colitis 
rs1132005	8165183	SEC16A	9	0.174659	0.0812133	1.93E-05	Ankylosing spondylitis 
rs1132005	8165183	SEC16A	9	0.174659	0.0812133	1.93E-05	Crohn's disease 
rs1132005	8165183	SEC16A	9	0.174659	0.0812133	1.93E-05	Ulcerative colitis 
rs959903	8099721	SEL1L3	4	0.160755	0.0958338	5.37E-06	Non-alcoholic fatty liver disease histology (other)
rs757978	8049827	SEPT2	2	-0.246285	0.198007	1.71E-29	Chronic lymphocytic leukemia
rs12694997	8049827	SEPT2	2	0.340121	0.0493653	9.19E-12	Height
rs606452	7942596	SERPINH1	11	0.131598	0.141164	1.11E-05	Height
rs73530203	7994985	SETD1A	16	-0.210421	0.0477455	1.34E-05	Psoriasis 
rs2031532	7969114	SETDB2	13	-0.218965	0.0960931	2.30E-09	Cardiac hypertrophy
rs1518366	8058024	SF3B1	2	0.231845	0.107418	6.46E-06	Crohn's disease 
rs2336725	8088065	SFMBT1	3	-0.393196	0.077385	4.31E-24	Height
rs2304856	8019061	SGSH	17	0.2559	0.0467445	6.15E-08	Psoriasis 
rs12157904	8072847	SH3BP1	22	-0.245982	0.120036	6.28E-07	Response to antidepressant treatment
rs1318937	8085556	SH3BP5	3	-0.209306	0.0477097	1.55E-05	Alcohol and nictotine co-dependence
rs1318937	8085556	SH3BP5	3	-0.209306	0.0477097	1.55E-05	Alcohol dependence
rs9876781	8086953	SHISA5	3	0.156963	0.0850082	9.39E-05	Longevity
rs6788895	8091485	SIAH2	3	-0.270902	0.145905	8.80E-11	Breast cancer
rs508487	7944049	SIDT2	11	0.418025	0.0488041	2.15E-17	Cardiovascular disease risk factors
rs1263173	7944049	SIDT2	11	-0.371727	0.0984696	3.07E-24	Coronary heart disease
rs7396835	7944049	SIDT2	11	-0.40632	0.0752774	2.24E-28	Quantitative traits
rs2075292	7944049	SIDT2	11	-0.507432	0.0900447	8.26E-51	Triglycerides
rs4938303	7944049	SIDT2	11	-0.240061	0.0470629	4.65E-07	Triglycerides
rs2810114	7975459	SIPA1L1	14	0.225558	0.0607884	8.29E-06	Alcohol dependence
rs2073643	8107909	SLC22A4	5	0.198906	0.116261	4.52E-10	Asthma
rs56399423	8107909	SLC22A4	5	0.387048	0.0596101	9.61E-17	Crohn's disease 
rs272889	8107909	SLC22A4	5	0.299423	0.0924288	7.11E-16	Metabolic traits
rs2070729	8107909	SLC22A4	5	-0.152089	0.0941548	1.83E-05	Platelet counts
rs2073643	8107920	SLC22A5	5	0.402951	0.155798	2.74E-60	Asthma
rs56399423	8107920	SLC22A5	5	0.501597	0.162773	3.93E-63	Crohn's disease 
rs2522056	8107920	SLC22A5	5	-0.127273	0.124637	4.64E-06	Fibrinogen
rs272889	8107920	SLC22A5	5	0.0787944	0.267921	2.06E-20	Metabolic traits
rs2070729	8107920	SLC22A5	5	-0.176561	0.167173	5.32E-15	Platelet counts
rs2242285	8080896	SLC25A26	3	0.198547	0.0637802	1.94E-05	Ventricular conduction
rs2766692	7981283	SLC25A29	14	0.31241	0.049467	2.74E-12	Electroencephalographic traits in alcoholism
rs1417210	7928208	SLC29A3	10	0.358899	0.126733	1.29E-18	Vitiligo
rs12600277	8001750	SLC38A7	16	-0.270097	0.172841	2.01E-13	Aortic root size
rs7386474	8153262	SLC45A4	8	-0.23913	0.0771783	3.55E-09	Bipolar disorder and schizophrenia
rs780094	8051030	SLC5A6	2	0.233295	0.047325	1.13E-06	Crohn's disease 
rs1260333	8051030	SLC5A6	2	0.193896	0.0915656	4.59E-07	Triglycerides
rs255049	7996772	SLC7A6	16	0.306736	0.0453663	2.21E-11	HDL cholesterol
rs6499165	7996772	SLC7A6	16	-0.209472	0.163353	2.59E-17	Metabolic traits
rs4287819	8063351	SLC9A8	20	-0.211532	0.0478232	1.31E-05	Psoriasis 
rs1502844	8113369	SLCO4C1	5	-0.242205	0.060108	4.49E-08	Schizophrenia
rs2665838	8017460	SMARCD2	17	-0.316316	0.102926	5.60E-18	Height
rs2070776	8017460	SMARCD2	17	-0.167338	0.0904794	9.52E-05	Height
rs35734725	7908097	SMG7	1	0.192281	0.157219	4.68E-09	Systemic lupus erythematosus 
rs1927702	8154394	SNAPC3	9	0.21921	0.0604897	1.41E-05	Body mass index
rs116599416	8101762	SNCA	4	0.228698	0.143114	2.28E-16	Parkinson's disease
rs4886707	7990528	SNUPN	15	-0.214583	0.11636	5.17E-11	Height
rs10894294	7952768	SNX19	11	0.14499	0.200301	8.86E-12	Schizophrenia
rs62027635	8001373	SNX20	16	-0.257413	0.0519828	8.93E-07	Crohn's disease 
rs9302752	8001373	SNX20	16	-0.406039	0.0551085	2.77E-23	Leprosy
rs9727115	7903203	SNX7	1	-0.239596	0.177322	2.00E-09	Proinsulin levels
rs1371867	8147661	SPAG1	8	-0.264204	0.162614	1.11E-16	Atrioventricular conduction
rs6065	8011765	SPAG7	17	-0.162988	0.157549	4.38E-12	Platelet counts
rs2590838	8080438	SPCS1	3	-0.280739	0.0461285	1.71E-09	Adiponectin levels
rs2239547	8080438	SPCS1	3	-0.189665	0.0814941	8.69E-06	Schizophrenia
rs35175818	7994518	SPNS1	16	-0.245473	0.123252	5.96E-13	Crohn's disease 
rs26528	7994518	SPNS1	16	-0.155107	0.0961894	1.06E-05	Inflammatory bowel disease
rs12325113	7994518	SPNS1	16	-0.315184	0.0690555	2.96E-14	Type 1 diabetes 
rs3796619	8098870	SPON2	4	-0.129174	0.161671	1.38E-05	Recombination rate (males)
rs2066938	7967091	SPPL3	12	0.194106	0.04816	7.46E-05	Metabolic traits
rs1039302	7967091	SPPL3	12	-0.312915	0.0753602	2.34E-11	Quantitative traits
rs2657888	7956257	SPRYD4	12	-0.146011	0.149636	5.16E-10	Adiponectin levels
rs2657880	7956257	SPRYD4	12	-0.271527	0.146945	4.76E-22	Metabolite levels
rs2250402	7987449	SRP14	15	0.252119	0.0654739	1.40E-07	Corneal curvature
rs17761864	8003722	SRR	17	0.420307	0.151702	1.89E-58	Esophageal cancer (squamous cell)
rs3110496	8013965	SSH2	17	-0.27194	0.0715603	3.52E-08	Height
rs6784615	8080344	STAB1	3	-0.118304	0.133616	1.85E-06	Waist-hip ratio
rs11869286	8006877	STARD3	17	0.233832	0.0939367	5.41E-08	HDL cholesterol
rs4723738	8132376	STARD3NL	7	0.392215	0.0423827	4.61E-20	Treatment response for severe sepsis 
rs11171803	7964119	STAT2	12	0.317702	0.0530946	3.18E-09	Psoriasis 
rs11172113	7964360	STAT6	12	0.227644	0.0473651	2.10E-06	Migraine
rs11172113	7964360	STAT6	12	0.227644	0.0473651	2.10E-06	Pulmonary function
rs11172113	7964360	STAT6	12	0.227644	0.0473651	2.10E-06	Pulmonary function (interaction)
rs6749447	8056545	STK39	2	0.564986	0.0728676	1.90E-85	Blood pressure
rs10760706	8156861	STX17	9	0.228009	0.0565239	4.08E-06	Alopecia areata
rs7299940	7967685	STX2	12	0.14611	0.134083	2.69E-07	Panic disorder
rs7304057	7967685	STX2	12	0.295363	0.0689432	2.08E-11	Response to amphetamines
rs6565217	7995017	STX4	16	-0.245642	0.0468998	2.24E-07	Psoriasis 
rs6798928	8083422	SUCNR1	3	0.212983	0.0563602	2.15E-05	Immunoglobulin A 
rs1968751	8000590	SULT1A1	16	0.221209	0.196992	2.13E-06	Crohn's disease 
rs11171747	7956097	SUOX	12	-0.19614	0.102174	1.82E-06	Systemic sclerosis 
rs10876864	7956097	SUOX	12	-0.272437	0.153814	5.08E-18	Type 1 diabetes 
rs2257205	8016982	SUPT4H1	17	-0.197635	0.0704436	3.35E-05	Pancreatic cancer
rs7872515	8156393	SUSD3	9	0.0867043	0.178626	2.99E-06	Bipolar disorder and schizophrenia
rs10992471	8156393	SUSD3	9	0.185923	0.0806789	3.46E-06	Visceral adipose tissue/subcutaneous adipose tissue ratio
rs2986971	7932796	SVIL	10	-0.202972	0.102662	1.48E-08	Non-alcoholic fatty liver disease histology (lobular)
rs712022	7947147	SVIP	11	-0.222358	0.0774776	2.00E-07	Dialysis-related mortality
rs1322512	8130211	SYNE1	6	-0.340973	0.13139	2.21E-24	Tonometry
rs2263759	8062964	SYS1	20	-0.315596	0.0450928	4.31E-12	Psoriasis 
rs2282301	7906061	SYT11	1	0.199901	0.128797	2.46E-08	Conduct disorder (interaction)
rs508487	7944082	TAGLN	11	0.279425	0.090646	1.11E-08	Cardiovascular disease risk factors
rs1263173	7944082	TAGLN	11	-0.373884	0.0430782	8.04E-18	Coronary heart disease
rs7396835	7944082	TAGLN	11	-0.255245	0.106637	1.17E-13	Quantitative traits
rs2075292	7944082	TAGLN	11	-0.361793	0.106637	5.90E-22	Triglycerides
rs4938303	7944082	TAGLN	11	-0.194268	0.0481145	7.24E-05	Triglycerides
rs10492096	7953341	TAPBPL	12	0.253834	0.0522062	1.42E-06	Hip geometry
rs12772169	7929424	TBC1D12	10	0.30243	0.0454421	4.52E-11	Acenocoumarol maintenance dosage
rs1046896	8010848	TBCD	17	0.259979	0.0467112	3.53E-08	Glycated hemoglobin levels
rs6429082	7910651	TBCE	1	0.271209	0.0516291	1.10E-08	Adiposity
rs1799884	8139482	TBRG4	7	-0.197439	0.0924069	5.65E-05	Glycated hemoglobin levels
rs1799884	8139482	TBRG4	7	-0.197439	0.0924069	5.65E-05	Glycemic traits
rs1799884	8139482	TBRG4	7	-0.197439	0.0924069	5.65E-05	Metabolite levels
rs6488898	7959638	TCTN2	12	0.245006	0.052421	3.62E-06	Adiponectin levels
rs4886238	7969341	TDRD3	13	-0.188165	0.0684157	5.58E-05	Menopause (age at onset)
rs11622475	7977161	TDRD9	14	-0.387049	0.0508265	1.16E-20	Bipolar disorder
rs3764419	8014047	TEFM	17	-0.210188	0.0477858	1.47E-05	Height
rs151361	8063697	TH1L	20	0.191765	0.048045	8.79E-05	Mean platelet volume
rs13137105	8095760	THAP6	4	-0.216664	0.0476076	7.26E-06	Response to tocilizumab in rheumatoid arthritis
rs4072037	7920664	THBS3	1	-0.359973	0.0436382	3.08E-16	Magnesium levels
rs3859192	8007008	THRA	17	-0.22999	0.15977	2.55E-08	White blood cell count
rs2540226	8051746	THUMPD2	2	-0.221065	0.0476182	4.68E-06	Personality dimensions
rs1568657	7985493	TM6SF1	15	-0.52388	0.0882924	1.96E-51	Kawasaki disease
rs319690	8079630	TMA7	3	0.191264	0.0537989	6.00E-05	Blood pressure
rs9876781	8079630	TMA7	3	0.429046	0.10482	6.57E-34	Longevity
rs9876781	7899346	TMA7	3	0.343281	0.111853	6.66E-20	Longevity
rs730566	8079630	TMA7	3	-0.275248	0.101155	5.20E-11	Prion diseases
rs730566	7899346	TMA7	3	-0.22986	0.0704388	1.12E-06	Prion diseases
rs6809216	8079630	TMA7	3	0.216521	0.0489678	7.08E-06	Ulcerative colitis 
rs6815464	8098916	TMEM129	4	-0.209073	0.0478754	1.70E-05	Type 2 diabetes
rs1077989	7979721	TMEM229B	14	-0.522241	0.0366017	1.10E-45	Phospholipid levels (plasma)
rs261360	8064833	TMEM230	20	0.26441	0.0787278	2.54E-09	Hair morphology
rs1463984	8157092	TMEM38B	9	-0.243855	0.0469606	2.87E-07	Cognitive performance
rs10903129	7899005	TMEM50A	1	0.191466	0.124492	2.13E-10	"Cholesterol, total"
rs10903129	7899005	TMEM50A	1	0.191466	0.124492	2.13E-10	Erythrocyte sedimentation rate
rs6465825	8140500	TMEM60	7	0.200901	0.0739997	2.74E-06	Chronic kidney disease
rs4963128	7937438	TMEM80	11	0.236046	0.080909	4.16E-08	Systemic lupus erythematosus 
rs16934812	7962058	TMTC1	12	-0.197718	0.0480498	5.21E-05	Schizophrenia
rs10197940	8045688	TNFAIP6	2	0.208108	0.0824688	1.62E-07	Lung cancer
rs4227	8004464	TNFSF12-TNFSF13	17	0.238544	0.194249	2.79E-27	IgA nephropathy
rs1077667	8033248	TNFSF14	19	0.315182	0.0657534	2.00E-06	Multiple sclerosis 
rs3810936	8163618	TNFSF15	9	0.479612	0.090464	7.65E-43	Crohn's disease 
rs6478108	8163618	TNFSF15	9	0.480498	0.0892754	4.55E-42	Leprosy
rs3810936	8163618	TNFSF15	9	0.479612	0.090464	7.65E-43	Ulcerative colitis 
rs907611	7937728	TNNI2	11	0.243545	0.0471251	3.28E-07	Inflammatory bowel disease
rs56344095	7937728	TNNI2	11	0.245678	0.0470434	2.42E-07	Ulcerative colitis 
rs3757387	8142852	TNPO3	7	0.24698	0.0634007	1.28E-08	Ulcerative colitis 
rs11868035	8013159	TOM1L2	17	0.249443	0.0515565	6.38E-08	Parkinson's disease
rs1325195	7907690	TOR3A	1	0.322763	0.0448712	1.08E-12	IgE grass sensitization
rs7561273	8050702	TP53I3	2	-0.245464	0.0767392	3.23E-07	Quantitative traits
rs896854	8151890	TP53INP1	8	0.633324	0.030307	2.61E-96	Type 2 diabetes
rs10937405	8084766	TP63	3	-0.202096	0.0479333	3.35E-05	Lung adenocarcinoma
rs35264875	7942091	TPCN2	11	-0.294294	0.0668693	2.25E-08	Blond vs. brown hair color
rs3750965	7942091	TPCN2	11	-0.20709	0.1374	5.77E-06	Hair color
rs2652834	7984079	TPM1	15	-0.224375	0.0529181	2.71E-05	HDL cholesterol
rs11071720	7984079	TPM1	15	-0.197226	0.0572377	2.29E-05	Mean platelet volume
rs801193	8133155	TPST1	7	-0.393183	0.0440239	2.91E-20	Aortic root size
rs861020	7909455	TRAF3IP3	1	-0.244913	0.0470992	2.77E-07	Orofacial clefts
rs9834970	8086125	TRANK1	3	0.237061	0.0472183	7.11E-07	"Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)"
rs9834970	8086125	TRANK1	3	0.237061	0.0472183	7.11E-07	Bipolar disorder
rs2302189	8017106	TRIM37	17	0.465519	0.0497584	4.95E-32	Dental caries
rs4929949	7946380	TRIM66	11	-0.30995	0.0474171	6.90E-12	Body mass index
rs391300	8011245	TSR1	17	-0.172296	0.117921	5.42E-05	Type 2 diabetes
rs1547014	8075142	TTC28	22	-0.188207	0.0958043	5.14E-05	Vertical cup-disc ratio
rs1003719	8068522	TTC3	21	-0.455508	0.0596913	1.65E-34	Eye color traits
rs2245641	8160213	TTC39B	9	0.16781	0.0902374	2.39E-05	Bipolar disorder
rs12003180	8160213	TTC39B	9	-0.300042	0.182823	1.46E-17	Bipolar disorder and schizophrenia
rs581080	8160213	TTC39B	9	0.327269	0.0979562	1.28E-19	"Cholesterol, total"
rs581080	8160213	TTC39B	9	0.327269	0.0979562	1.28E-19	HDL cholesterol
rs11082762	8020630	TTC39C	18	0.299973	0.0454885	6.77E-11	Amyotrophic lateral sclerosis
rs11082762	8020647	TTC39C	18	0.273324	0.046314	5.20E-09	Amyotrophic lateral sclerosis
rs2411453	8000603	TUFM	16	0.484631	0.0599898	4.24E-43	Crohn's disease 
rs7187776	8000603	TUFM	16	-0.59107	0.0336024	3.11E-72	Type 1 diabetes 
rs3788317	8074498	TXNRD2	22	0.219333	0.047661	5.70E-06	Glaucoma (primary open-angle)
rs140522	8077103	TYMP	22	-0.258322	0.13855	1.20E-15	Red blood cell traits
rs56987708	8046685	UBE2E3	2	0.22077	0.0823452	1.67E-07	Ankylosing spondylitis 
rs7602460	8046685	UBE2E3	2	-0.163414	0.092054	5.35E-05	Atrioventricular conduction
rs5754217	8071547	UBE2L3	22	-0.380915	0.0428961	1.38E-18	Red blood cell traits
rs46522	8008139	UBE2Z	17	0.590859	0.0555333	7.23E-87	Coronary heart disease
rs2038823	7972369	UGGT2	13	0.204125	0.127573	3.98E-09	Diabetic retinopathy 
rs11683229	8042270	UGP2	2	-0.241958	0.0663912	1.61E-08	Protein quantitative trait loci
rs11755393	8118833	UHRF1BP1	6	-0.805112	0.0444266	2.10E-302	Systemic lupus erythematosus 
rs2472304	7990400	ULK3	15	0.21783	0.119266	1.04E-11	Caffeine consumption
rs6495122	7990400	ULK3	15	0.224501	0.101887	5.10E-10	Caffeine consumption
rs4886615	7990400	ULK3	15	0.584795	0.0332495	1.18E-68	Celiac disease 
rs6495122	7990400	ULK3	15	0.224501	0.101887	5.10E-10	Coffee consumption
rs6495122	7990400	ULK3	15	0.224501	0.101887	5.10E-10	Diastolic blood pressure
rs1052501	8086372	ULK4	3	0.653043	0.0785523	6.39E-178	Multiple myeloma
rs1052501	8086352	ULK4	3	0.618935	0.0437833	1.12E-85	Multiple myeloma
rs12618769	8043820	UNC50	2	0.178165	0.10368	3.41E-07	Bipolar disorder
rs801193	8133114	VKORC1L1	7	0.230447	0.0473568	1.55E-06	Aortic root size
rs7178424	7989387	VPS13C	15	0.267567	0.0464969	1.23E-08	Height
rs4905558	7976621	VRK1	14	-0.204145	0.0740867	4.13E-06	Neutrophil count
rs10857636	7927425	WDFY4	10	-0.383089	0.052065	2.42E-15	Response to antidepressant treatment
rs10857636	7927405	WDFY4	10	-0.262824	0.0519169	5.01E-07	Response to antidepressant treatment
rs163030	8112746	WDR41	5	0.364307	0.119069	1.59E-20	Caudate nucleus volume
rs7617480	8079693	WDR6	3	0.511621	0.131999	1.59E-37	Menarche (age at onset)
rs730566	8079693	WDR6	3	-0.151204	0.146822	4.66E-09	Prion diseases
rs7623659	8079693	WDR6	3	-0.177734	0.147518	2.20E-07	Ulcerative colitis 
rs11209261	7916862	WLS	1	0.179319	0.0806611	7.61E-06	Airflow obstruction 
rs240702	8000482	XPO6	16	0.194338	0.0481536	7.30E-05	Crohn's disease 
rs2291617	7956648	XRCC6BP1	12	0.253377	0.0588372	1.59E-07	Multiple sclerosis 
rs881827	8069340	YBEY	21	0.216858	0.0476756	7.34E-06	Lymphocyte counts
rs73166632	8074780	YPEL1	22	0.169833	0.0704739	6.45E-05	Celiac disease 
rs73166632	8074780	YPEL1	22	0.169833	0.0704739	6.45E-05	Crohn's disease 
rs73166632	8074780	YPEL1	22	0.169833	0.0704739	6.45E-05	Psoriasis 
rs1012068	8072577	YWHAH	22	0.202674	0.0479304	3.17E-05	Chronic Hepatitis C infection
rs6440003	8083090	ZBTB38	3	-0.527195	0.0430513	1.27E-49	Height
rs6440003	8083092	ZBTB38	3	-0.526153	0.0439922	2.31E-49	Height
rs10513137	8083090	ZBTB38	3	-0.253269	0.127343	1.31E-16	Height
rs10513137	8083092	ZBTB38	3	-0.255633	0.0888388	2.52E-11	Height
rs9857275	8083090	ZBTB38	3	-0.270368	0.0982244	4.89E-09	Prion diseases
rs9857275	8083092	ZBTB38	3	-0.24041	0.0879839	5.28E-07	Prion diseases
rs12478601	8051814	ZFP36L2	2	-0.207533	0.0478585	1.96E-05	Polycystic ovary syndrome
rs9929218	7996807	ZFP90	16	0.214968	0.126855	2.31E-12	Colorectal cancer
rs3203684	7996807	ZFP90	16	-0.532051	0.0361158	1.32E-48	Ulcerative colitis 
rs319690	8079598	ZNF589	3	-0.282751	0.107115	6.38E-11	Blood pressure
rs9876781	8079598	ZNF589	3	-0.225005	0.0987858	2.83E-09	Longevity
rs730566	8079598	ZNF589	3	0.177049	0.100547	6.38E-05	Prion diseases